The market cap about 18 months ago when the stock was $1 or so, was over $1 Billion!!! There were about 1.1 billion shares outstanding then.
I don't know how to do a market cap chart, sorry.
Nobody is gonna buy them because they don't own the tech, they license everything. Advent does all the billing, then takes out the cost and adds a guaranteed 15% profit. What is left over gets split by NWBO and UCLA for the lic. fee. (why would BP buy into this?)
Big pharma buys only original proprietary IP.. BP could easily lic. other techs from universities, like NWBO did. They also have ZERO "sales and marketing" team, only 22 employees in a garage like operation. SurVaxM , IMO is the one to watch from MimiVax. There are also many CAR-T promising therapies and some mRNA genetic therapies that BP has their eyes on.
Just my opinions, do your own research. Some companies sell products, and some companies only sell their own stock. You figure it out for yourself. lol
Frankly, I am amazed that they maintain the current market cap. I think it is because there are NO institutions that own it, so (they can't sell it! if they don't own it) Just about 38,000 individual shareholders that are so beat down in the share price, that they don't sell - easier to wait for a miracle while their investment is so close to zero already. (the downside is so small at this point for them) The only seller of shares has been N.W.B.O.!!!! consistently over the years. Again, these are my opinions, not investment advice.
Market Data 
Markets 
AI
